Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum

TAKESHI FUJISAWA, HIDEHIRO HOJO, MASAKI NAKAMURA, KENJI MAKITA, HIDENARI HIRATA, HIDEKAZU OYOSHI, KENTO TOMIZAWA, YUZHENG ZHOU, KEIKO FUKUSHI, MASAFUMI IKEDA and SADAMOTO ZENDA
Anticancer Research March 2025, 45 (3) 1159-1169; DOI: https://doi.org/10.21873/anticanres.17503
TAKESHI FUJISAWA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEHIRO HOJO
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hhojo{at}east.ncc.go.jp
MASAKI NAKAMURA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI MAKITA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
2Department of Radiation Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDENARI HIRATA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEKAZU OYOSHI
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTO TOMIZAWA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUZHENG ZHOU
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEIKO FUKUSHI
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAFUMI IKEDA
3Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SADAMOTO ZENDA
1Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 45 (3)
Anticancer Research
Vol. 45, Issue 3
March 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum
TAKESHI FUJISAWA, HIDEHIRO HOJO, MASAKI NAKAMURA, KENJI MAKITA, HIDENARI HIRATA, HIDEKAZU OYOSHI, KENTO TOMIZAWA, YUZHENG ZHOU, KEIKO FUKUSHI, MASAFUMI IKEDA, SADAMOTO ZENDA
Anticancer Research Mar 2025, 45 (3) 1159-1169; DOI: 10.21873/anticanres.17503

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinical Outcomes of Patients Receiving Stereotactic Body Radiotherapy Dose De-escalation for Hepatocellular Carcinoma at the Hepatic Hilum
TAKESHI FUJISAWA, HIDEHIRO HOJO, MASAKI NAKAMURA, KENJI MAKITA, HIDENARI HIRATA, HIDEKAZU OYOSHI, KENTO TOMIZAWA, YUZHENG ZHOU, KEIKO FUKUSHI, MASAFUMI IKEDA, SADAMOTO ZENDA
Anticancer Research Mar 2025, 45 (3) 1159-1169; DOI: 10.21873/anticanres.17503
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Relationship Between Dose and Local Control in Five-fraction Stereotactic Body Radiotherapy for Hepatocellular Carcinoma
  • Google Scholar

More in this TOC Section

  • Over-expression of Anillin Actin Binding Protein in Adrenocortical Carcinoma Tissues Is Associated With Poorer Prognosis of Patients
  • Clinicopathological Significance of HER2 Expression Redefined by the HER2-low Concept in Ductal Carcinoma In Situ
  • Radiotherapy Strategies for Stage II Breast Cancer With Lymphovascular Invasion After Mastectomy
Show more Clinical Studies

Keywords

  • local recurrence
  • hepatocellular carcinoma
  • stereotactic body radiation therapy
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire